133 Publications (Page 4 of 6)
2009
Phase I Trial of High-Dose Clofarabine and Busulfan as a Myeloablative Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute LeukemiaFarag, Sherif⋅Farag, Sherif⋅Wood, Lisa L⋅Wood, Lisa L⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Srivastava, Shivani⋅Srivastava, Shivani⋅Nelson, Robert P⋅Nelson, Robert P⋅Robertson, Michael⋅Robertson, Michael⋅Abonour, Rafat⋅Abonour, Rafat⋅Sayar, Hamid⋅Sayar, Hamid⋅Cripe, Larry D and Cripe, Larry DBlood, vol. 114, (no. 22), pp. 198, 2009-11-20.
| Journal Article
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First RelapseLevis, Mark⋅Ravandi, Farhad⋅Wang, Eunice S⋅Baer, Maria R⋅Perl, Alexander⋅Coutre, Steven⋅Erba, Harry⋅Stuart, Robert K⋅Baccarani, Michele⋅Cripe, Larry D⋅Tallman, Martin S⋅Meloni, Giovanna⋅Godley, Lucy A⋅Langston, Amelia A⋅Amadori, Sergio⋅Lewis, Ian D⋅Nagler, Arnon⋅Stone, Richard⋅Yee, Karen⋅Advani, Anjali⋅Douer, Dan⋅Jedrzejczak, Wieslaw W⋅Juliusson, Gunnar⋅Litzow, Mark R⋅Petersdorf, Stephen⋅Sanz, Miguel⋅Kantarjian, Hagop M⋅Sato, Takashi⋅Tremmel, Lothar⋅Bensen-Kennedy, Debra M⋅Small, Donald and Smith, B. DouglasBlood, vol. 114, (no. 22), pp. 788, 2009-11-20.
| Journal Article
T.133. Post-Engraftment Anti-CD25 for the Prevention of Acute Graft-versus-host disease (GVHD) after Minimally Intensive Cyclophosphamide/Fludarabine (Cy/Flu) Conditioning and Hematopoietic Cell TransplantationNelson, Robert⋅Nelson, Robert⋅Nelson, R.⋅Robertson, Michael⋅Robertson, M.⋅Robertson, Michael⋅Schwartz, J.⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Cornetta, Kenneth⋅Cornetta, Kenneth⋅Cornetta, Kenneth G⋅Srivastava, Shivani⋅Srivastava, Shivani⋅Srivastava, Shivani⋅Kiel, Patrick⋅Kiel, Patrick⋅Kiel, P.⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Wood, Lisa⋅Wood, L.⋅Wood, Lisa⋅Baute, John⋅Baute, J.⋅Baute, John⋅O'Bryant, R.⋅O'Bryant, Robin⋅O'Bryant, Robin⋅Cripe, L.⋅Cripe, Larry⋅Cripe, Larry⋅Abonour, Rafat⋅Abonour, R.⋅Abonour, Rafat⋅Farag, Sherif⋅Farag, S. and Farag, SherifClinical Immunology, vol. 131, pp. S91, 2009.
| Journal Article
The Discovered Story: The Evolution of Truth in Cancer NarrativesCripe, LarryLiterature and Medicine, vol. 28, (no. 2), pp. vi-x, Fall 2009.
| Journal Article
Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress ApoptosisShanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Wilson-Weekes, Annique⋅Wilson-Weekes, Annique⋅Sayar, Hamid⋅Sayar, Hamid⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Sargent, Katie J⋅Sargent, Katie J⋅Cripe, Larry D⋅Cripe, Larry D⋅Kalvakolanu, Dhananjaya V⋅Kalvakolanu, Dhananjaya V⋅Boswell, H. Scott and Boswell, H. ScottBlood, vol. 114, (no. 22), pp. 2387, 2009-11-20.
| Journal Article
2008
Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, Is Well-Tolerated and Has Significant Clinical Activity in Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (SLL/CLL)Friedberg, Jonathan W⋅Sharman, Jeff⋅Schaefer-Cutillo, Julia⋅Johnston, Patrick B⋅De Vos, Sven⋅LaCasce, Ann⋅Leonard, John P⋅Cripe, Larry D⋅Sinha, Rajni⋅Gregory, Stephanie A⋅Sweetenham, John⋅Vose, Julie M⋅Lowe, Ann M⋅Levy, R and Shipp, Margaret ABlood, vol. 112, (no. 11), pp. 3, 2008-11-16.
| Journal Article
Lenalidomide and Prednisone for Primary and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II TrialMesa, Ruben A⋅Yao, Xiaopan⋅Cripe, Larry D⋅Li, Chin Yang⋅Tefferi, Ayalew and Tallman, Martin SBlood, vol. 112, (no. 11), pp. 1753, 2008-11-16.
| Journal Article
Music imagery for adults with acute leukemia in protective environments: a feasibility study.Burns, Debra S⋅Azzouz, Faouzi⋅Sledge, Renata⋅Rutledge, Cheryl⋅Hincher, Katie⋅Monahan, Patrick O and Cripe, Larry DSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 16, (no. 5), pp. 507-13, 2008/May.
| Journal Article
Phase 2 Study of Voreloxin (Formerly Known as SNS-595) as Single Agent Therapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Preliminary Safety and Clinical Responses (The REVEAL-1 Study)Maris, Michael⋅Cripe, Larry D⋅Stuart, Robert K⋅Ravandi, Farhad⋅Michelson, Glenn C⋅Hawtin, Rachel E⋅Ericson, Lyra E and Berman, Craig JBlood, vol. 112, (no. 11), pp. 1951, 2008-11-16.
| Journal Article
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromesGiagounidis, Aristoteles⋅Fenaux, Pierre⋅Mufti, Ghulam⋅Muus, Petra⋅Platzbecker, Uwe⋅Sanz, Guillermo⋅Cripe, Larry⋅Von Lilienfeld-Toal, Marie and Wells, RichardAnnals of Hematology, vol. 87, (no. 5), pp. 345-52, May 2008.
| Journal Article
Preliminary Results of a Phase 1/2, Multi-Center, Open-Label Study (CLL- 001) Investigating a Stepwise Dose-Escalation Schedule of Lenalidomide in Relapsed or Refractory Chronic Lymphocytic LeukemiaWendtner, Clemens M⋅Mahadevan, Daruka⋅Stilgenbauer, Stephan⋅Frankfurt, Olga⋅Bloor, Adrian⋅Bosch, Francesc⋅Uharek, Lutz⋅Furman, Richard R⋅Gobbi, Marco⋅Gribben, John G⋅Kimby, Eva K⋅Sekeres, Mikkael A⋅Cripe, Larry D⋅Lombardy, Elyane⋅Shah, Sheetal⋅Parseval, Laure A Moutouh-de⋅Chanan-Khan, Asher Alban and Knight, Robert DBlood, vol. 112, (no. 11), pp. 2104, 2008-11-16.
| Journal Article
The end-of-life discussion: a second opinion on 'hope'Cripe, Larry and Wong, MichaelHEM/ONC Today, vol. 9, (no. 16), pp. 5, 20080910.
| Journal Article
Treating low-risk myelodysplastic syndromes in the community settingCripe, Larry DClinical advances in hematology & oncology : H&O, vol. 6, (no. 6), pp. 418, 2008-Jun.
| Journal Article
Voreloxin (formerly known as SNS-595) in Combination with Cytarabine Demonstrates Preliminary Clinical Responses in a Phase 1 Study in Relapsed/Refractory Acute Myeloid LeukemiaLancet, Jeffrey⋅Karp, Judith E⋅Cripe, Larry D⋅Roboz, Gail J⋅Suster, Matt⋅Tan, Nguyen⋅Hawtin, Rachael⋅Fox, Judith⋅Berman, Craig and Michelson, GlennBlood, vol. 112, (no. 11), pp. 1955, 2008-11-16.
| Journal Article
2007
A 3,239 -Patient Combined Eastern Cooperative Oncology Group (ECOG), M.D. Anderson Cancer Center (MDA) Analysis of the Effect of CR vs. Responses < CR on Long-Term Survival in Newly-Diagnosed AML Treated with Ara-C-Containing Regimens: Implications for Targeted Drug DevelopmentEstey, Elihu⋅Sun, Zhuoxin⋅Rowe, Jacob⋅Faderl, Stefan⋅Cassileth, Peter⋅Sartiano, George⋅Tartaglia, Anthony⋅Garcia-Manero, Guillermo⋅Cripe, Larry⋅Bennett, John⋅Kantarjian, Hagop and Tallman, MartinBlood, vol. 110, (no. 11), pp. 298, 2007-11-16.
| Journal Article
A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.Fenaux, Pierre⋅Fenaux, Pierre⋅Raza, Azra⋅Raza, Azra⋅Mufti, Ghulam J⋅Mufti, Ghulam J⋅Aul, Carlo⋅Aul, Carlo⋅Germing, Ulrich⋅Germing, Ulrich⋅Kantarjian, Hagop⋅Kantarjian, Hagop⋅Cripe, Larry⋅Cripe, Larry⋅Kerstens, RenĂ©⋅Kerstens, RenĂ©⋅De Porre, Peter⋅De Porre, Peter⋅Kurzrock, Razelle and Kurzrock, RazelleBlood, vol. 109, (no. 10), pp. 4158-4163, May 15, 2007.
| Journal Article
A Woman with Facial Papules and Pulmonary NodulesErickson, Bradley W⋅Erickson, Bradley W⋅Erickson, Bradley W⋅Cripe, Larry⋅Cripe, Larry⋅Cripe, Larry⋅Rieger, Karen⋅Rieger, Karen⋅Rieger, Karen⋅Cummings, Oscar W⋅Cummings, Oscar W⋅Cummings, Oscar W⋅Wilkes, David⋅Wilkes, David and Wilkes, DavidRespiration, vol. 74, (no. 4), pp. 474, 20070700.
| Journal Article
A Woman with Facial Papules and Pulmonary NodulesErickson, Bradley⋅Cripe, Larry⋅Rieger, Karen⋅Cummings, Oscar and Wilkes, David(pp. 471-4). Jul 2007
Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Fausel, Christopher⋅Fausel, Christopher⋅Juliar, Beth⋅Juliar, Beth E⋅Yiannoutsos, Constantin T⋅Yiannoutsos, Constantin⋅Fisher, William B⋅Fisher, William⋅Ansari, Rafat⋅Ansari, Rafat H⋅Wood, Lisa L⋅Wood, Lisa⋅Smith, Gina G⋅Smith, Gina⋅Cripe, Larry D⋅Cripe, Larry⋅Abonour, Rafat and Abonour, RafatThe Oncologist, vol. 12, (no. 1), pp. 106, 20070101.
| Journal Article
Mechanistic Paradigm for Combination Signal Transduction Inhibitor Therapy in Zap70+ CLL Involves Bicompartmental Functions of EZH2Hartman, Amy D⋅Wilson-Weekes, Annique⋅Ruffin, Theresa⋅Hincher, Katie J⋅Cripe, Larry D and Boswell, H. ScottBlood, vol. 110, (no. 11), pp. 3099, 2007-11-16.
| Journal Article
Phase I/II Study of the P-Glycoprotein (Pgp) Inhibitor Zosuquidar Administered by Continuous Infusion (CIV) with Daunorubicin (DNR) and Cytarabine (ARA-C) as Primary Therapy in Older Patients with Pgp-Positive Acute Myeloid Leukemia (AML)Lancet, Jeffrey E⋅Gotlib, Jason⋅Wetzler, Meir⋅Luger, Selina⋅Cripe, Larry D⋅Tallman, Martin S⋅Gojo, Ivana⋅Mulford, Deborah⋅Baer, Maria R⋅List, Alan F⋅Multani, Pratik S and Sikic, Branimir IBlood, vol. 110, (no. 11), pp. 299, 2007-11-16.
| Journal Article
2006
A piece of my mind. Hope is the thing with feathers.Cripe, Larry DJAMA : the journal of the American Medical Association, vol. 296, (no. 15), pp. 1815-6, 2006/Oct/18.
| Journal Article
A Randomized, Placebo-Controlled, Double Blind Trial of the MDR Modulator, Zosuquidar, during Conventional Induction and Post-Remission Therapy for Pts > 60 Years of Age with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS): ECOG 3999Cripe, Larry D⋅Li, Xiaochun⋅Litzow, Mark⋅Paietta, Elisabeth⋅Rowe, Jacob M⋅Luger, Selina and Tallman, MartinBlood, vol. 108, (no. 11), pp. 423, 2006-11-16.
| Journal Article
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.Hartman, Amy D⋅Wilson-Weekes, Annique⋅Suvannasankha, Attaya⋅Burgess, Gem S⋅Phillips, Carissa A⋅Hincher, Katie J⋅Cripe, Larry D and Boswell, H ScottExperimental hematology, vol. 34, (no. 10), pp. 1360-1376, October 2006.
| Journal Article
Desensitization to imatinib in patients with leukemiaNelson, Robert P⋅Nelson, Robert P⋅Cornetta, Kenneth G⋅Cornetta, Kenneth⋅Ward, Kelly E⋅Ward, Kelly E⋅Ramanuja, Srinivasan⋅Ramanuja, Srinivasan⋅Fausel, Chris⋅Fausel, Chris⋅Cripe, Larry D and Cripe, Larry DAnnals of Allergy, Asthma & Immunology, vol. 97, (no. 2), pp. 222, 2006.
| Journal Article